Trial Outcomes & Findings for Time Interval for Endoscopic Variceal Ligation (NCT NCT01291277)
NCT ID: NCT01291277
Last Updated: 2017-02-13
Results Overview
Recruitment status
COMPLETED
Study phase
PHASE4
Target enrollment
90 participants
Primary outcome timeframe
At 4 weeks
Results posted on
2017-02-13
Participant Flow
Participant milestones
| Measure |
Ligation: 1-week Interval
Endoscopic variceal ligation performed at 1-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
Ligation 2-week Interval
Endoscopic variceal ligation performed at 2-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
|---|---|---|
|
Overall Study
STARTED
|
45
|
45
|
|
Overall Study
COMPLETED
|
40
|
42
|
|
Overall Study
NOT COMPLETED
|
5
|
3
|
Reasons for withdrawal
| Measure |
Ligation: 1-week Interval
Endoscopic variceal ligation performed at 1-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
Ligation 2-week Interval
Endoscopic variceal ligation performed at 2-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
|---|---|---|
|
Overall Study
Death
|
2
|
2
|
|
Overall Study
Lost to Follow-up
|
3
|
1
|
Baseline Characteristics
Time Interval for Endoscopic Variceal Ligation
Baseline characteristics by cohort
| Measure |
Ligation: 1-week Interval
n=45 Participants
Endoscopic variceal ligation performed at 1-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
Ligation 2-week Interval
n=45 Participants
Endoscopic variceal ligation performed at 2-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
Total
n=90 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
53 years
n=5 Participants
|
54 years
n=7 Participants
|
54 years
n=5 Participants
|
|
Gender
Female
|
14 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
21 Participants
n=5 Participants
|
|
Gender
Male
|
31 Participants
n=5 Participants
|
38 Participants
n=7 Participants
|
69 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: At 4 weeksOutcome measures
| Measure |
Ligation: 1-week Interval
n=45 Participants
Endoscopic variceal ligation performed at 1-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
Ligation 2-week Interval
n=45 Participants
Endoscopic variceal ligation performed at 2-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
|---|---|---|
|
Proportion of Patients With Eradication of Esophageal Varices
|
37 Participants
|
23 Participants
|
Adverse Events
Ligation: 1-week Interval
Serious events: 16 serious events
Other events: 4 other events
Deaths: 0 deaths
Ligation 2-week Interval
Serious events: 15 serious events
Other events: 1 other events
Deaths: 0 deaths
Serious adverse events
| Measure |
Ligation: 1-week Interval
n=45 participants at risk
Endoscopic variceal ligation performed at 1-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
Ligation 2-week Interval
n=45 participants at risk
Endoscopic variceal ligation performed at 2-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
|---|---|---|
|
General disorders
Hospitalization
|
35.6%
16/45
|
33.3%
15/45
|
Other adverse events
| Measure |
Ligation: 1-week Interval
n=45 participants at risk
Endoscopic variceal ligation performed at 1-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
Ligation 2-week Interval
n=45 participants at risk
Endoscopic variceal ligation performed at 2-week intervals
Endoscopic Variceal Ligation: Ligation of esophageal varices
|
|---|---|---|
|
Gastrointestinal disorders
Esophageal
|
8.9%
4/45
|
2.2%
1/45
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place